Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WDR7 antisense RNA 1 (WDR7-AS1) is a long non-coding RNA transcribed from the antisense strand adjacent to the WDR7 gene. Like other lncRNAs and antisense RNAs, WDR7-AS1 likely functions in the regulation of gene expression, potentially through mechanisms such as chromatin modification, regulation of mRNA stability, or interference with transcription[1][3]. WDR7-AS1 is not a protein-coding gene and is not currently considered a therapeutic target. Its biological roles remain largely uncharacterized, but by analogy to neighboring antisense lncRNAs, it may contribute to cell cycle regulation, apoptosis, and disease via modulation of WDR7 or other nearby genes[3].
None established for drug interaction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WDR7 antisense RNA 1 (WDR7-AS1).